| Quarterly Financials | Dec 2025 | Mar 2026 |
Revenue  | 90 | 111 |
| Expenses | 60 | 77 |
| EBITDA | 31 | 34 |
| Operating Profit % | 33 % | 29 % |
| Depreciation | 2 | 5 |
| Interest | 5 | 6 |
| Profit Before Tax | 23 | 23 |
| Tax | 6 | 6 |
| Net Profit | 17 | 17 |
| EPS in ₹ | 10.68 | 10.46 |
Q-Line Biotech
Q-Line Biotech
525.85
+16.20
(3.18%)
Market Cap
1,226.71 Cr
PE Ratio
42.26
Volume
4,03,200.00
Day High - Low
542.00 - 501.00
52W High-Low
528.90 - 343.00
Key Fundamentals
Market Cap
1,226.71 Cr
EPS
28.63
PE Ratio
42.26
PB Ratio
2.75
Book Value
185.35
EBITDA
83.20
Dividend Yield
0.00 %
Industry
Healthcare Sector
Medical Equipment Return on Equity
12.91
Debt to Equity
0.75
Actual
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,573.20 | #1 15,945.87 | 48.61 | #1 1,875.26 | 6.61 | #1 326 | -29.19 | 59.92 | |
267.32 | 1,422.31 | 103.59 | 422.51 | 3.45 | 16 | -58.82 | 70.60 | |
525.85 | #3 1,226.71 | #5 42.26 | #4 322.60 | #3 56.30 | #4 25 | - | 63.77 | |
223.03 | 1,225.82 | 42.74 | 271.50 | 12.00 | 22 | #1 134.88 | 51.31 | |
472.80 | 836.60 | 29.18 | 292.67 | 56.84 | 30 | - | 44.35 | |
156.77 | 696.86 | #1 18.43 | 410.77 | 22.29 | 36 | 46.36 | 55.25 | |
378.40 | 656.02 | 64.96 | 278.87 | 10.97 | 10 | -68.29 | 40.29 | |
375.95 | 546.51 | 29.29 | 231.81 | #1 107.34 | 19 | - | 52.29 | |
391.00 | 469.30 | 23.51 | 71.81 | 7.02 | 21 | 13.73 | 49.14 | |
160.20 | 305.02 | 59.11 | 54.75 | -59.83 | 5 | - | 40.12 |
Growth Rate
Revenue Growth
56.30 %
Net Income Growth
13.43 %
Cash Flow Change
-
ROE
-3.44 %
ROCE
15.00 %
EBITDA Margin (Avg.)
30.45 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 |
| Total Assets | 252 | 339 | 456 |
| Fixed Assets | 23 | 60 | 74 |
| Current Assets | 176 | 199 | 265 |
| Capital Work in Progress | 12 | 19 | 63 |
| Investments | 0 | 0 | 0 |
| Other Assets | 217 | 260 | 319 |
| Total Equity & Liabilities | 252 | 339 | 456 |
| Current Liabilities | 108 | 140 | 179 |
| Non Current Liabilities | 16 | 37 | 86 |
| Total Equity | 127 | 162 | 190 |
| Reserve & Surplus | 126 | 160 | 188 |
| Share Capital | 2 | 2 | 2 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | 25 | -52 | -7 |
| Investing Activities | -26 | -45 | -59 |
| Operating Activities | 25 | -24 | -1 |
| Financing Activities | 26 | 17 | 53 |
Share Holding
| % Holding | Sept 2025 | May 2026 |
| Promoter | 96.77 % | 67.51 % |
| FIIs | 0.00 % | 1.67 % |
| DIIs | 0.00 % | 10.14 % |
| Government | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 15.97 % |
| Others | 3.23 % | 4.70 % |
| No of Share Holders | 0 | 3,497 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 17 Jun 2026 |  Quarterly Result Announcement | NA | 17 Jun 2026 | 504.35 | 502.15 |
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Abakkus Small Cap Fund Direct-Growth | 1.72% | 0 | 0.00% | 1.72% |
Technical Indicators
RSI(14)
Oversold 0.00
ATR(14)
Volatile 0.00
STOCH(9,6)
Oversold 0.00
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish 0.00
ADX(14)
Weak Trend 0.00
UO(9)
Bullish 0.00
ROC(12)
Uptrend And Accelerating 12.42
WillR(14)
Overbought -19.66
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
